Rainbow Coral Corp. (RBCC) Pursues JV Involving Revolutionary Breakthrough in $60 Billion Drug Delivery Market
Rainbow Coral today announced that its biotech division, Rainbow BioSciences, is currently in talks to help develop and market a revolutionary, sustained-release drug delivery platform that could soon enable safer delivery of biologic agents and small molecules, while also increasing efficacy and convenience to a whole new level. Specifically, a joint venture agreement with a privately held drug delivery company developing the novel technology is on the table. The local delivery platform is being developed to address the issues posed by systemic drug delivery, including oral and IV delivery. Often systemically delivered drugs can’t reach sufficient concentrations in target organs…